Company Filing History:

18 out of 206

Sterling Winthrop Inc.

patents

Years Active: 1991-1999

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5856349 - 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic (1999-01-05),

2. 5773456 - Saccharin derivative proteolytic enzyme inhibitors (1998-06-30),

3. 5750550 - 2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides (1998-05-12),

4. 5652254 - 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic (1997-07-29),

5. 5650422 - Saccharin derivatives useful as proteolytic enzyme inhibitors and (1997-07-22),

6. 5597841 - 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme (1997-01-28),

7. 5596012 - Saccharin derivatives useful as proteolytic enzyme inhibitors and (1997-01-21),

8. 5578623 - Saccharin derivative proteolytic enzyme inhibitors (1996-11-26),

9. 5563163 - 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic (1996-10-08),

10. 5512589 - 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme (1996-04-30),

11. 5512576 - 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions (1996-04-30),

12. 5494925 - 2-heterocyclyloxymethyl and (1996-02-27),

13. 5488062 - 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic (1996-01-30),

14. 5466701 - Saccharin derivative proteolytic enzyme inhibitors (1995-11-14),

15. 5464852 - Saccharin derivative proteolytic enzyme inhibitors (1995-11-07),

Title: Celebrating the Innovations of Inventor Dennis J Hlasta

Introduction

Dennis J Hlasta, a prolific inventor based in Clifton Park, NY, has made significant contributions to the field of chemistry and pharmacology. With an impressive portfolio of 24 patents, his innovations have paved the way for advancements in therapeutic treatments.

Latest Patents

Among his notable recent inventions are two patents focused on 2-Saccharinylmethyl heterocyclic carboxylates. These compounds are designed for use as proteolytic enzyme inhibitors, particularly in the treatment of degenerative diseases. The development involves a method of preparing these derivatives by reacting a 4-R.sup.4 -R.sup.5 -2-halomethylsaccharin with a heterocyclic carboxylic acid in the presence of an acid-acceptor or the alkali metal salt of said acid. His work on saccharin derivative proteolytic enzyme inhibitors is recognized for its potential therapeutic benefits.

Career Highlights

Throughout his career, Dennis J Hlasta has been associated with several notable organizations, including Sterling Winthrop Inc. and Sanofi. His expertise and innovative spirit have significantly contributed to the advancements within these companies, making him a respected figure in his field.

Collaborations

In his journey, Dennis has collaborated with esteemed professionals such as Ranjit C Desai and Richard P Dunlap. These partnerships have facilitated an exchange of ideas and fostered innovation, resulting in groundbreaking advancements in their projects.

Conclusion

Dennis J Hlasta's work exemplifies the spirit of innovation, showcasing how scientific research and collaboration can lead to impactful inventions. His contributions to the field of pharmacology not only demonstrate his talent as an inventor but also highlight the importance of continuous research in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.